These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28608011)

  • 1. Safety of Anticoagulation Interruption in Patients Undergoing Surgery or Invasive Procedures: A Systematic Review and Meta-analyses of Randomized Controlled Trials and Non-randomized Studies.
    Hovaguimian F; Köppel S; Spahn DR
    World J Surg; 2017 Oct; 41(10):2444-2456. PubMed ID: 28608011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of perioperative anticoagulation interruption without heparin bridging on thromboembolic events in patients with atrial fibrillation undergoing elective invasive procedures: a systematic review protocol.
    Kaur J; Thomas L; Bhat A; Barker TH
    JBI Evid Synth; 2023 Nov; 21(11):2227-2238. PubMed ID: 37338287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic and bleeding risk of periprocedural bridging anticoagulation: A systematic review and meta-analysis.
    Kuo HC; Liu FL; Chen JT; Cherng YG; Tam KW; Tai YH
    Clin Cardiol; 2020 May; 43(5):441-449. PubMed ID: 31944351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis.
    Ayoub K; Nairooz R; Almomani A; Marji M; Paydak H; Maskoun W
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2215-21. PubMed ID: 27289185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bridge to Nowhere? Benefits and Risks for Periprocedural Anticoagulation in Atrial Fibrillation.
    Krishnamoorthy A; Ortel T
    Curr Cardiol Rep; 2016 Oct; 18(10):101. PubMed ID: 27568795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
    Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis.
    Yong JW; Yang LX; Ohene BE; Zhou YJ; Wang ZJ
    BMC Cardiovasc Disord; 2017 Dec; 17(1):295. PubMed ID: 29237411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
    Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
    N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Not Available].
    Vink R; Huisman MV
    Ned Tijdschr Geneeskd; 2015; 159():A9652. PubMed ID: 26556495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.
    Pappas MA; Barnes GD; Vijan S
    J Gen Intern Med; 2017 Apr; 32(4):464-470. PubMed ID: 28120297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
    Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L; Zhang Y; Wang W; Hou Y
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural management of oral anticoagulation in patients with atrial fibrillation: approach in the era of new oral anticoagulants.
    Healey JS; Brambatti M
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S54-9. PubMed ID: 23790599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of Safety and Efficacy of Anticoagulation versus no Anticoagulation in Octogenarians and Nonagenarians with Atrial Fibrillation.
    Barssoum K; Kumar A; Thakkar S; Sheth AR; Kharsa A; Ibrahim M; Rai D; Idemudia O; Akula N; Patel HP; Mowafy A; Elkaryoni A; Ibrahim F; Mubasher M; Ghattas KN; Rao M
    High Blood Press Cardiovasc Prev; 2021 May; 28(3):271-282. PubMed ID: 33742366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.